These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 334211)

  • 61. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.
    Wilcox RG; Bennett T; Macdonald IA; Broughton Pipkin F; Baylis PH
    Br J Clin Pharmacol; 1987 Aug; 24(2):151-62. PubMed ID: 2887189
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Atenolol and three nonselective beta-blockers in hypertension.
    Waal-Manning HJ
    Clin Pharmacol Ther; 1979 Jan; 25(1):8-18. PubMed ID: 31259
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
    Simon G; Franciosa JA; Gimenez HJ; Cohn JN
    Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Treatment of essential mild-to-moderate arterial hypertension with once-daily penbutolol. Controlled clinical study vs atenolol].
    Nami R; Martinelli M; Bianchini C; Gennari C
    Minerva Med; 1988 Nov; 79(11):965-71. PubMed ID: 3059235
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension.
    Rubin PC; Butters L; Clark DM; Reynolds B; Sumner DJ; Steedman D; Low RA; Reid JL
    Lancet; 1983 Feb; 1(8322):431-4. PubMed ID: 6131164
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acute effect of atenolol on hemodynamic, plasma renin activity and plasma aldosterone concentration in the once daily oral administration.
    Sasaki Y; Arakawa K
    Jpn Circ J; 1984 Sep; 48(9):988-93. PubMed ID: 6384568
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of monotherapy with enalapril and atenolol in mild to moderate hypertension. The Canadian Enalapril Study Group.
    CMAJ; 1987 Nov; 137(9):803-8. PubMed ID: 2894890
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Jun; 17(6):425-60. PubMed ID: 38096
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of once-daily atenolol on ambulatory blood pressure.
    Craig MW; Kenny D; Mann S; Balasubramanian V; Raftery EB
    Br Med J; 1979 Jan; 1(6158):237-8. PubMed ID: 421051
    [No Abstract]   [Full Text] [Related]  

  • 71. [Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension].
    Herpin D; Boutaud P; Ciber MA; Amiel A; Demange J
    Ann Cardiol Angeiol (Paris); 1987 Nov; 36(9):487-93. PubMed ID: 2892458
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The prolonged antihypertensive effect of once daily atenolol: a study of continuous non-invasive arterial blood pressure monitoring.
    Roudaut R; Wicker P; Junca F; Clementy J; Dallocchio M
    Eur Heart J; 1984 Aug; 5(8):668-74. PubMed ID: 6479194
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparative study of atenolol and penbutolol in hypertensive patients.
    Lameijer LD; Houtzagers JJ; Voermans LA
    Eur Heart J; 1983 Jul; 4 Suppl D():53-6. PubMed ID: 6352272
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical and haemodynamic study of atenolol (Tenormin) in essential hypertension.
    Jensen HA; Rasmussen K; Mosbaek N
    Clin Sci Mol Med Suppl; 1976 Dec; 3():525s-526s. PubMed ID: 799562
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antihypertensive effect of atenolol (100 mg once a day) and methyldopa (250 mg thrice a day). A double-blind cross-over multicentre study.
    Kristensen BO; Brøns M; Christensen CK; Geday E; Jacobsen FK; Jensen SN; Linde NC
    Acta Med Scand; 1981; 209(4):267-70. PubMed ID: 7015798
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Atenolol in hypertension.
    Petrie JC; Jeffers TA; Webster J
    Am Heart J; 1977 Mar; 93(3):407-8. PubMed ID: 320854
    [No Abstract]   [Full Text] [Related]  

  • 77. Atenolol and chlorthalidone in combination in the management of older hypertensive patients: a randomized clinical trial.
    Backhouse CI; Hosie J; Tweed JA; Edwards KG
    Curr Med Res Opin; 1985; 9(6):378-83. PubMed ID: 3886301
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent.
    Ros FE; Dake CL; Offerhaus L; Greve EL
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1977 Dec; 205(1):61-70. PubMed ID: 341739
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A double-blind comparison of atenolol ('Tenormin') and methyldopa in the treatment of moderate hypertension in general practice: a multicentre study.
    Basker MA; Tweed JA; Barker NP
    Curr Med Res Opin; 1977; 4(9):618-26. PubMed ID: 338252
    [No Abstract]   [Full Text] [Related]  

  • 80. Relationship between blood level of atenolol and pharmacologic effect.
    Amery A; De Plaen JF; Lijnen P; McAinsh J; Reybrouck T
    Clin Pharmacol Ther; 1977 Jun; 21(6):691-9. PubMed ID: 324694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.